Showing 1061-1070 of 7691 results for "".
Antioxidants and Skin Cancer Risk: A Look at Vitamins A and B
https://practicaldermatology.com/topics/skin-cancer-photoprotection/antioxidants-and-skin-cancer-risk-a-look-at-vitamins-a-and-b/23106/There is some evidence to suggest that higher intake of these antioxidants may reduce skin cancer risks.The State of Pediatric Dermatology
https://practicaldermatology.com/topics/practice-management/the-state-of-pediatric-dermatology/23060/The subspecialty needs to expand its workforce to continue to meet critical patient need.The Showdown: Smartphone vs. DSLR Cameras
https://practicaldermatology.com/topics/practice-management/the-showdown-smartphone-vs-dslr-cameras/23031/Consistently capturing great photos can have a huge impact on your practice. Here’s what to consider.A Novel Therapeutic Option for the Treatment of Molluscum Contagiosum
https://practicaldermatology.com/topics/general-topics/a-novel-therapeutic-option-for-the-treatment-of-molluscum-contagiosum/21040/There is no FDA approved treatment for molluscum. A novel intervention may erradicate Molluscum with one treatment.How NEMLUVIO® Works
https://practicaldermatology.com/programs/nemluvio-peer-network/how-nemluvio-works/37226/Learn how NEMLUVIO® works to directly block IL-31RA from Dr Peter Lio, a leading dermatologist, with extensive experience in treating neuroimmune skin diseases.Angioleiomyoma in a Rare Location
https://practicaldermatology.com/topics/other-dermatology/angioleiomyoma-in-a-rare-location/24012/A minimally invasive treatment is used to treat a tumor in a cosmetically sensitive area.The Art of Patient Scheduling
https://practicaldermatology.com/topics/practice-management/the-art-of-patient-scheduling/23676/Is your patient scheduling system working as efficiently as possible? Put these five action items in place to ensure your practice is firing on all cylinders.Rosacea Update: A Closer Look at Zilxi
https://practicaldermatology.com/columns/clinical-focus-1/rosacea-update-a-closer-look-at-zilxi/23339/Inside the approval of Zilxi for moderate-to-severe facial papulopustular rosacea.Biosimilars: Generic Biologics or Something Much More Complex?
https://practicaldermatology.com/topics/practice-management/biosimilars-generic-biologics-or-something-much-more-complex/21013/The looming availability of biosimilar medications raises important clinical and regulatory questions.Understanding Zeltiq
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/understanding-zeltiq/21623/Practical considerations for integrating lasers and energy based devices in a dermatology practice.